18 November 2020 2 Min Read
Pfizer to seek regulatory approval within days as vaccine proves 95% effective
US drugmaker and partner BioNTech say vaccine protected people of all ages and ethnicities, with no significant safety problems in trials
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In